查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1587560

鼻腔药物和疫苗传输市场规模、份额、趋势分析报告：按产品、剂量、应用、分销管道、地区和细分市场预测，2025-2030 年

Intranasal Drug And Vaccine Delivery Market Size, Share & Trends Analysis Report By Product, By Dosage (Deep Learning, Machine Learning), By Application, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 100 Pages | 商品交期: 2-10个工作天内

价格

鼻腔药物和疫苗传输市场的成长和趋势

Grand View Research, Inc.的最新报告显示，到2030年，全球鼻腔药物和疫苗输送市场规模预计将达到1033.3亿美元，2025年至2030年复合年增长率预计为6.6%。

推动市场发展的关键因素之一是，人们越来越偏好鼻用製剂，而不是用于立即缓解症状的肠胃外和口服製剂。

需求的增加和技术的进步是主要的市场驱动因素。研究和开发投资的增加导致了适应于治疗各种病症的临床测试项目的升级。 2020 年 3 月，Auris Medical Holding Ltd. 提供了鼻内倍他司汀 (AM-125) 用于治疗急性周围性眩晕的 2 期测试的最新资讯。

慢性呼吸道疾病的日益普及增加了对鼻腔药物和疫苗设备的需求。根据美国疾病管制与预防美国(CDC) 的数据，2019 年，每 13 人就有 1 人患有气喘，超过 2,500 万美国患有气喘。 CDC 也表示，每年约有 1,420 万人次因气喘就诊、439,000 人出院、180 万人次急诊就诊。

液体输送装置在 2019 年占据市场主导地位，因为它们有多种配方可供选择，包括水溶液、乳液和悬浮液。由于各种疾病治疗的核准不断增加，预计该部门将出现良好的增长。此外，大多数正在开发的疫苗製剂都是单剂量製剂，医疗相关人员通常建议单剂量经鼻吸入型疫苗给药。

预计亚太地区将成为预测期内成长最快的区域市场。这主要是由于产品开发通讯协定的增加、经济成长以及更多参与企业当地市场从事开发新型药物输送系统。

鼻腔药物传输和疫苗输送市场报告亮点

  • 到 2024 年，液体输送装置将以 43.7% 的销售份额占据市场主导地位。这些装置，包括计量泵，可以避免首过代谢、提高生物有效性并提高治疗效果。
  • 多剂量系统在 2024 年以 64.1% 的销售份额引领市场。多剂量系统提高了耐受性和便利性，使患者能够以更少的补充量自行给药。
  • 由于鼻腔给药对气喘、慢性阻塞性肺病和过敏性鼻炎等疾病的有效性，呼吸系统疾病在 2024 年占据了最大的市场占有率，达到 41.1%。
  • 零售药局主导市场，2024年占45.1%的份额。这是由患者意识的提高和自我用药趋势的增长所推动的。

目录

第一章调查方法与范围

第 2 章执行摘要

第三章鼻腔药物和疫苗传输市场变数、趋势和范围

  • 市场体系展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 营商环境分析
    • 产业分析-波特五力分析
    • PESTLE分析

第四章鼻腔药物和疫苗输送市场：产品业务分析

  • 2024年及2030年产品市场占有率
  • 产品细分仪表板
  • 2018-2030 年按产品分類的市场规模、预测与趋势分析
  • 粉末输送装置
  • 液体输送装置（计量雾化帮浦）
  • 加压定量吸入器
  • 其他的

第五章鼻腔药物和疫苗传输市场：剂量业务分析

  • 2024 年及 2030 年剂量市场占有率
  • 剂量细分仪表板
  • 2018-2030 年市场规模、预测与趋势分析（按剂量）
  • 单一剂量
  • 多剂量

第六章鼻腔药物和疫苗输送市场：应用业务分析

  • 2024年及2030年应用市场占有率
  • 使用细分仪表板
  • 2018-2030 年市场规模、预测与趋势分析（按应用）
  • 呼吸系统疾病
  • 神经系统疾病
  • 疫苗接种
  • 疼痛管理
  • 其他的

第七章鼻腔药物和疫苗输送市场：分销通路业务分析

  • 2024 年及 2030 年分销通路市场占有率
  • 分销通路细分仪表板
  • 2018-2030 年按分销管道分類的市场规模、预测与趋势分析
  • 医院药房
  • 零售药房
  • 网路药房

第八章鼻腔药物和疫苗传输市场：按产品、剂量、应用和分销管道分類的区域、估计和趋势分析

  • 2024 年及 2030 年按地区分類的市场占有率分析
  • 区域市场仪表板
  • 2018-2030年市场规模、预测趋势分析
  • 北美洲
    • 按国家/地区划分，2018-2030
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 按国家/地区划分，2018-2030
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 丹麦
    • 瑞典
  • 亚太地区
    • 按国家/地区划分，2018-2030
    • 日本
    • 中国
    • 印度
    • 韩国
    • 澳洲
    • 泰国
  • 拉丁美洲
    • 按国家/地区划分，2018-2030
    • 巴西
    • 阿根廷
  • 中东/非洲
    • 按国家/地区划分，2018-2030
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第9章 竞争格局

  • 参与者概览
  • 公司市场分析
  • 公司分类
  • 策略规划
  • 公司简介/上市公司
    • GSK plc
    • Teva Pharmaceutical Industries Ltd
    • AptarGroup, Inc.
    • UCB SA, Belgium
    • Teleflex Incorporated
    • 3M
    • Bespak Limited
    • Optinose
    • Intersect ENT
Product Code: GVR-4-68038-479-6

Intranasal Drug And Vaccine Delivery Market Growth & Trends:

The global intranasal drug and vaccine delivery market size is estimated to reach USD 103.33 billion by 2030, registering to grow at a CAGR of 6.6% from 2025 to 2030 according to a new report by Grand View Research, Inc. Increasing preference for nasal products over parenteral and oral formulations for instant relief is one of the major factors driving the market.

Increasing demand and advancements in technology are some of the major market drivers. Rising investment in research and development has escalated the clinical trial programs indicated for the treatment of various conditions. In March 2020, Auris Medical Holding Ltd. provided the Phase 2 trial update for intranasal betahistine (AM-125) for the treatment of acute peripheral vertigo.

Increasing prevalence of chronic respiratory disorders augments the demand for intranasal drug and vaccine devices as they are commonly prescribed by medical professionals owing to the easy self-administration technique. According to the Centers for Disease Control and Prevention (CDC), in 2019, 1 in 13 people have asthma, with more than 25 million Americans living with asthma. CDC also stated that asthma accounted for an estimated 14.2 million hospital visits, 439,000 hospital discharges, and 1.8 million emergency department visits annually.

Liquid delivery devices dominated the market in 2019 on account of their availability in various formulations, including aqueous solutions, emulsions, and suspensions. The unit-does segment is anticipated to witness lucrative growth due to increasing approvals for the treatment of various disorders. Moreover, majority of the vaccine formulations under development are unit-dose formulations as single intranasal vaccine dose is commonly recommended by medical professionals.

Asia Pacific is expected to emerge as the fastest growing regional market over the forecast period. This is primarily attributed to increasing product development protocols, economic growth, and increase in the number of local market players involved in the development of novel drug delivery systems.

Intranasal Drug And Vaccine Delivery Market Report Highlights:

  • Liquid delivery devices dominated the market with a revenue share of 43.7% in 2024. These devices, including metered spray pumps, circumvent first-pass metabolism, enhancing bioavailability and accelerating therapeutic effects.
  • Multi-dose systems led the market with a revenue share of 64.1% in 2024. Multi-dose systems provide improved tolerance and convenience, enabling patients to self-administer medications with fewer refills.
  • Respiratory disorders held the largest market share of 41.1% in 2024, owing to the efficacy of intranasal delivery for conditions such as asthma, COPD, and allergic rhinitis.
  • Retail pharmacies dominated the market and accounted for a share of 45.1% in 2024, fueled by rising patient awareness and a growing trend towards self-administration of medications.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Product
    • 1.2.2. Dosage
    • 1.2.3. Application
    • 1.2.4. Distribution Channel
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Intranasal Drug and Vaccine Delivery Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
    • 3.2.2. Market Restraint Analysis
  • 3.3. Business Environment Analysis
    • 3.3.1. Industry Analysis - Porter's Five Forces Analysis
      • 3.3.1.1. Supplier Power
      • 3.3.1.2. Buyer Power
      • 3.3.1.3. Substitution Threat
      • 3.3.1.4. Threat of New Entrants
      • 3.3.1.5. Competitive Rivalry
    • 3.3.2. PESTLE Analysis

Chapter 4. Intranasal Drug and Vaccine Delivery Market: Product Business Analysis

  • 4.1. Product Market Share, 2024 & 2030
  • 4.2. Product Segment Dashboard
  • 4.3. Market Size & Forecasts and Trend Analysis, by Product, 2018 to 2030 (USD Million)
  • 4.4. Powder Delivery Device
    • 4.4.1. Powder Delivery Device Market, 2018 - 2030 (USD Million)
  • 4.5. Liquid Delivery Device (Metered Spray Pumps)
    • 4.5.1. Liquid Delivery Device (Metered Spray Pumps) Market, 2018 - 2030 (USD Million)
  • 4.6. Pressurized Metered Dose Inhaler
    • 4.6.1. Pressurized Metered Dose Inhaler Market, 2018 - 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others Market, 2018 - 2030 (USD Million)

Chapter 5. Intranasal Drug and Vaccine Delivery Market: Dosage Business Analysis

  • 5.1. Dosage Market Share, 2024 & 2030
  • 5.2. Dosage Segment Dashboard
  • 5.3. Market Size & Forecasts and Trend Analysis, by Dosage, 2018 to 2030 (USD Million)
  • 5.4. Unit-dose
    • 5.4.1. Unit-dose Market, 2018 - 2030 (USD Million)
  • 5.5. Multi-dose
    • 5.5.1. Multi-dose Market, 2018 - 2030 (USD Million)

Chapter 6. Intranasal Drug and Vaccine Delivery Market: Application Business Analysis

  • 6.1. Application Market Share, 2024 & 2030
  • 6.2. Application Segment Dashboard
  • 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2018 to 2030 (USD Million)
  • 6.4. Respiratory Disorders
    • 6.4.1. Respiratory Disorders Market, 2018 - 2030 (USD Million)
  • 6.5. Neurological Disorders
    • 6.5.1. Neurological Disorders Market, 2018 - 2030 (USD Million)
  • 6.6. Vaccination
    • 6.6.1. Vaccination Market, 2018 - 2030 (USD Million)
  • 6.7. Pain Management
    • 6.7.1. Pain Management Market, 2018 - 2030 (USD Million)
  • 6.8. Others
    • 6.8.1. Others Market, 2018 - 2030 (USD Million)

Chapter 7. Intranasal Drug and Vaccine Delivery Market: Distribution Channel Business Analysis

  • 7.1. Distribution Channel Market Share, 2024 & 2030
  • 7.2. Distribution Channel Segment Dashboard
  • 7.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2018 to 2030 (USD Million)
  • 7.4. Hospital Pharmacies
    • 7.4.1. Hospital Pharmacies Market, 2018 - 2030 (USD Million)
  • 7.5. Retail Pharmacies
    • 7.5.1. Retail Pharmacies Market, 2018 - 2030 (USD Million)
  • 7.6. Online Pharmacies
    • 7.6.1. Online Pharmacies Market, 2018 - 2030 (USD Million)

Chapter 8. Intranasal Drug and Vaccine Delivery Market: Regional Estimates & Trend Analysis by Product, Dosage, Application, and Distribution Channel

  • 8.1. Regional Market Share Analysis, 2024 & 2030
  • 8.2. Regional Market Dashboard
  • 8.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
  • 8.4. North America
    • 8.4.1. North America Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.4.2. U.S.
      • 8.4.2.1. Key Country Dynamics
      • 8.4.2.2. Regulatory Framework
      • 8.4.2.3. Competitive Insights
      • 8.4.2.4. U.S. Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.3. Canada
      • 8.4.3.1. Key Country Dynamics
      • 8.4.3.2. Regulatory Framework
      • 8.4.3.3. Competitive Insights
      • 8.4.3.4. Canada Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.4.4. Mexico
      • 8.4.4.1. Key Country Dynamics
      • 8.4.4.2. Regulatory Framework
      • 8.4.4.3. Competitive Insights
      • 8.4.4.4. Mexico Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.5. Europe
    • 8.5.1. Europe Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.5.2. UK
      • 8.5.2.1. Key Country Dynamics
      • 8.5.2.2. Regulatory Framework
      • 8.5.2.3. Competitive Insights
      • 8.5.2.4. UK Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.3. Germany
      • 8.5.3.1. Key Country Dynamics
      • 8.5.3.2. Regulatory Framework
      • 8.5.3.3. Competitive Insights
      • 8.5.3.4. Germany Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.4. France
      • 8.5.4.1. Key Country Dynamics
      • 8.5.4.2. Regulatory Framework
      • 8.5.4.3. Competitive Insights
      • 8.5.4.4. France Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.5. Italy
      • 8.5.5.1. Key Country Dynamics
      • 8.5.5.2. Regulatory Framework
      • 8.5.5.3. Competitive Insights
      • 8.5.5.4. Italy Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.6. Spain
      • 8.5.6.1. Key Country Dynamics
      • 8.5.6.2. Regulatory Framework
      • 8.5.6.3. Competitive Insights
      • 8.5.6.4. Spain Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.7. Norway
      • 8.5.7.1. Key Country Dynamics
      • 8.5.7.2. Regulatory Framework
      • 8.5.7.3. Competitive Insights
      • 8.5.7.4. Norway Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.8. Denmark
      • 8.5.8.1. Key Country Dynamics
      • 8.5.8.2. Regulatory Framework
      • 8.5.8.3. Competitive Insights
      • 8.5.8.4. Denmark Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.5.9. Sweden
      • 8.5.9.1. Key Country Dynamics
      • 8.5.9.2. Regulatory Framework
      • 8.5.9.3. Competitive Insights
      • 8.5.9.4. Sweden Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.6. Asia Pacific
    • 8.6.1. Asia Pacific Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.6.2. Japan
      • 8.6.2.1. Key Country Dynamics
      • 8.6.2.2. Regulatory Framework
      • 8.6.2.3. Competitive Insights
      • 8.6.2.4. Japan Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.3. China
      • 8.6.3.1. Key Country Dynamics
      • 8.6.3.2. Regulatory Framework
      • 8.6.3.3. Competitive Insights
      • 8.6.3.4. China Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.4. India
      • 8.6.4.1. Key Country Dynamics
      • 8.6.4.2. Regulatory Framework
      • 8.6.4.3. Competitive Insights
      • 8.6.4.4. India Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.5. South Korea
      • 8.6.5.1. Key Country Dynamics
      • 8.6.5.2. Regulatory Framework
      • 8.6.5.3. Competitive Insights
      • 8.6.5.4. South Korea Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.6. Australia
      • 8.6.6.1. Key Country Dynamics
      • 8.6.6.2. Regulatory Framework
      • 8.6.6.3. Competitive Insights
      • 8.6.6.4. Australia Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.6.7. Thailand
      • 8.6.7.1. Key Country Dynamics
      • 8.6.7.2. Regulatory Framework
      • 8.6.7.3. Competitive Insights
      • 8.6.7.4. Thailand Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.7. Latin America
    • 8.7.1. Latin America Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.7.2. Brazil
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Framework
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. Brazil Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.7.3. Argentina
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Framework
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Argentina Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
  • 8.8. MEA
    • 8.8.1. MEA Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, By Country, 2018 - 2030 (USD Million)
    • 8.8.2. South Africa
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Framework
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. South Africa Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.3. Saudi Arabia
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Framework
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Saudi Arabia Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.4. UAE
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Framework
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. UAE Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)
    • 8.8.5. Kuwait
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Framework
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Kuwait Intranasal Drug and Vaccine Delivery Market Estimates And Forecasts, 2018 - 2030 (USD Million)

Chapter 9. Competitive Landscape

  • 9.1. Participant Overview
  • 9.2. Company Market Position Analysis
  • 9.3. Company Categorization
  • 9.4. Strategy Mapping
  • 9.5. Company Profiles/Listing
    • 9.5.1. GSK plc
      • 9.5.1.1. Overview
      • 9.5.1.2. Financial Performance
      • 9.5.1.3. Product Benchmarking
      • 9.5.1.4. Strategic Initiatives
    • 9.5.2. Teva Pharmaceutical Industries Ltd
      • 9.5.2.1. Overview
      • 9.5.2.2. Financial Performance
      • 9.5.2.3. Product Benchmarking
      • 9.5.2.4. Strategic Initiatives
    • 9.5.3. AptarGroup, Inc.
      • 9.5.3.1. Overview
      • 9.5.3.2. Financial Performance
      • 9.5.3.3. Product Benchmarking
      • 9.5.3.4. Strategic Initiatives
    • 9.5.4. UCB S.A., Belgium
      • 9.5.4.1. Overview
      • 9.5.4.2. Financial Performance
      • 9.5.4.3. Product Benchmarking
      • 9.5.4.4. Strategic Initiatives
    • 9.5.5. Teleflex Incorporated
      • 9.5.5.1. Overview
      • 9.5.5.2. Financial Performance
      • 9.5.5.3. Product Benchmarking
      • 9.5.5.4. Strategic Initiatives
    • 9.5.6. 3M
      • 9.5.6.1. Overview
      • 9.5.6.2. Financial Performance
      • 9.5.6.3. Product Benchmarking
      • 9.5.6.4. Strategic Initiatives
    • 9.5.7. Bespak Limited
      • 9.5.7.1. Overview
      • 9.5.7.2. Financial Performance
      • 9.5.7.3. Product Benchmarking
      • 9.5.7.4. Strategic Initiatives
    • 9.5.8. Optinose
      • 9.5.8.1. Overview
      • 9.5.8.2. Financial Performance
      • 9.5.8.3. Product Benchmarking
      • 9.5.8.4. Strategic Initiatives
    • 9.5.9. Intersect ENT
      • 9.5.9.1. Overview
      • 9.5.9.2. Financial Performance
      • 9.5.9.3. Product Benchmarking
      • 9.5.9.4. Strategic Initiatives

List of Tables

  • Table 1 List of secondary sources
  • Table 2 List of abbreviations
  • Table 3 Global intranasal drug and vaccine delivery market, by region, 2018 - 2030 (USD Million)
  • Table 4 Global intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 5 Global intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 6 Global intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 7 Global intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 8 North America intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
  • Table 9 North America intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 10 North America intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 11 North America intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 12 North America intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 13 U.S intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 14 U.S intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 15 U.S intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 16 U.S intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 17 Canada intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 18 Canada intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 19 Canada intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 20 Canada intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 21 Mexico intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 22 Mexico intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 23 Mexico intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 24 Mexico intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 25 Europe intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
  • Table 26 Europe intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 27 Europe intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 28 Europe intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 29 Europe intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 30 UK intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 31 UK intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 32 UK intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 33 UK intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 34 Germany intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 35 Germany intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 36 Germany intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 37 Germany intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 38 France intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 39 France intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 40 France intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 41 France intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 42 Italy intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 43 Italy intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 44 Italy intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 45 Italy intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 46 Spain intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 47 Spain intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 48 Spain intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 49 Spain intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 50 Denmark intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 51 Denmark intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 52 Denmark intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 53 Denmark intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 54 Sweden intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 55 Sweden intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 56 Sweden intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 57 Sweden intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 58 Norway intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 59 Norway intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 60 Norway intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 61 Norway intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 62 Asia Pacific intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
  • Table 63 Asia Pacific intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 64 Asia Pacific intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 65 Asia Pacific intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 66 Asia Pacific intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 67 China intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 68 China intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 69 China intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 70 China intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 71 Japan intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 72 Japan intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 73 Japan intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 74 Japan intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 75 India intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 76 India intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 77 India intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 78 India intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 79 Australia intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 80 Australia intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 81 Australia intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 82 Australia intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 83 South Korea intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 84 South Korea intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 85 South Korea intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 86 South Korea intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 87 Thailand intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 88 Thailand intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 89 Thailand intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 90 Thailand intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 91 Latin America intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
  • Table 92 Latin America intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 93 Latin America intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 94 Latin America intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 95 Latin America intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 96 Brazil intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 97 Brazil intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 98 Brazil intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 99 Brazil intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 100 Argentina intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 101 Argentina intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 102 Argentina intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 103 Argentina intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 104 Middle East & Africa Intranasal drug and vaccine delivery market, by country, 2018 - 2030 (USD Million)
  • Table 105 Middle East & Africa intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 106 Middle East & Africa intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 107 Middle East & Africa intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 108 Middle East & Africa intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 109 South Africa intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 110 South Africa intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 111 South Africa intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 112 South Africa intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 113 Saudi Arabia intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 114 Saudi Arabia intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 115 Saudi Arabia intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 116 Saudi Arabia intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 117 UAE intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 118 UAE intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 119 UAE intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 120 UAE intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)
  • Table 121 Kuwait intranasal drug and vaccine delivery market, by product, 2018 - 2030 (USD Million)
  • Table 122 Kuwait intranasal drug and vaccine delivery market, by dosage, 2018 - 2030 (USD Million)
  • Table 123 Kuwait intranasal drug and vaccine delivery market, by application, 2018 - 2030 (USD Million)
  • Table 124 Kuwait intranasal drug and vaccine delivery market, by distribution channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Intranasal drug and vaccine delivery market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Market research approaches
  • Fig. 6 Value-chain-based sizing & forecasting
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Product and dosage outlook (USD Million)
  • Fig. 10 Application and distribution channel outlook
  • Fig. 11 Competitive landscape
  • Fig. 12 Intranasal drug and vaccine delivery market dynamics
  • Fig. 13 Intranasal drug and vaccine delivery market: Porter's five forces analysis
  • Fig. 14 Intranasal drug and vaccine delivery market: PESTLE analysis
  • Fig. 15 Intranasal drug and vaccine delivery market: Product segment dashboard
  • Fig. 16 Intranasal drug and vaccine delivery market: Product market share analysis, 2024 & 2030
  • Fig. 17 Powder delivery device market, 2018 - 2030 (USD Million)
  • Fig. 18 Liquid delivery device (metered spray pumps) market, 2018 - 2030 (USD Million)
  • Fig. 19 Pressurized metered dose inhaler market, 2018 - 2030 (USD Million)
  • Fig. 20 Others market, 2018 - 2030 (USD Million)
  • Fig. 21 Intranasal drug and vaccine delivery market: Dosage segment dashboard
  • Fig. 22 Intranasal drug and vaccine delivery market: Dosage market share analysis, 2024 & 2030
  • Fig. 23 Unit-dose market, 2018 - 2030 (USD Million)
  • Fig. 24 Multi-dose market, 2018 - 2030 (USD Million)
  • Fig. 25 Intranasal drug and vaccine delivery market: Application segment dashboard
  • Fig. 26 Intranasal drug and vaccine delivery market: Application market share analysis, 2024 & 2030
  • Fig. 27 Respiratory disorders market, 2018 - 2030 (USD Million)
  • Fig. 28 Neurological disorders market, 2018 - 2030 (USD Million)
  • Fig. 29 Vaccination market, 2018 - 2030 (USD Million)
  • Fig. 30 Pain management market, 2018 - 2030 (USD Million)
  • Fig. 31 Others market, 2018 - 2030 (USD Million)
  • Fig. 32 Intranasal drug and vaccine delivery market: Distribution channel segment dashboard
  • Fig. 33 Intranasal drug and vaccine delivery market: Distribution channel market share analysis, 2024 & 2030
  • Fig. 34 Hospital pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 35 Retail pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 36 Online pharmacies market, 2018 - 2030 (USD Million)
  • Fig. 37 Intranasal drug and vaccine delivery market revenue, by region
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Regional marketplace: Key takeaways
  • Fig. 40 North America intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 41 U.S. country dynamics
  • Fig. 42 U.S. intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 43 Canada country dynamics
  • Fig. 44 Canada intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 45 Mexico country dynamics
  • Fig. 46 Mexico intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 47 Europe intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 48 UK country dynamics
  • Fig. 49 UK intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 50 Germany country dynamics
  • Fig. 51 Germany intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 52 France country dynamics
  • Fig. 53 France intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 54 Italy country dynamics
  • Fig. 55 Italy intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 56 Spain country dynamics
  • Fig. 57 Spain intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 58 Norway country dynamics
  • Fig. 59 Norway intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 60 Sweden country dynamics
  • Fig. 61 Sweden intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 62 Denmark country dynamics
  • Fig. 63 Denmark intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 64 Asia Pacific intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 65 Japan country dynamics
  • Fig. 66 Japan intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 67 China country dynamics
  • Fig. 68 China intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 69 India country dynamics
  • Fig. 70 India intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 71 Australia country dynamics
  • Fig. 72 Australia intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 73 South Korea country dynamics
  • Fig. 74 South Korea intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 75 Thailand country dynamics
  • Fig. 76 Thailand intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 77 Latin America intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 78 Brazil country dynamics
  • Fig. 79 Brazil intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 80 Argentina country dynamics
  • Fig. 81 Argentina intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 82 MEA intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 83 South Africa country dynamics
  • Fig. 84 South Africa intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 85 Saudi Arabia country dynamics
  • Fig. 86 Saudi Arabia intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 87 UAE country dynamics
  • Fig. 88 UAE intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 89 Kuwait country dynamics
  • Fig. 90 Kuwait intranasal drug and vaccine delivery market, 2018 - 2030 (USD Million)
  • Fig. 91 Company categorization
  • Fig. 92 Company market position analysis
  • Fig. 93 Strategic framework